Enzon gets delisting notice

NASDAQ notifies Enzon Pharmaceuticals (ENZN) that it no longer meets its listing requirement of a minimum of $1/share. The company has 180 days to regain compliance (December 8, 2014) by having its stock trade at $1/share or higher for 10 consecutive business days during the 180-day period.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs